Cartilage tissue engineering: From proinflammatory and anti‑inflammatory cytokines to osteoarthritis treatments (Review)
Тканевая инженерия хряща: от провоспалительных и противовоспалительных цитокинов к методам лечения остеоартрита (обзор)
2022-01-24
SCID: 54.1/a7ptr8ud
Discuss with AI
Anti-inflammatory cytokinesCartilage tissue engineeringMesenchymal stem cellsOsteoarthritisProinflammatory cytokines
Figures from the paper
Abstract (AI)
Osteoarthritis (OA), one of the most common joint diseases, is characterized by fibrosis, rhagadia, ulcers and attrition of articular cartilage due to a number of factors. The etiology of OA remains unclear, but its occurrence has been associated with age, obesity, inflammation, trauma and genetic factors. Inflammatory cytokines are crucial for the occurrence and progression of OA. The intra‑articular proinflammatory and anti‑inflammatory cytokines jointly maintain a dynamic balance, in accordance with the physiological metabolism of articular cartilage. However, dynamic imbalance between proinflammatory and anti‑inflammatory cytokines can cause abnormal metabolism in knee articular cartilage, which leads to deformation, loss and abnormal regeneration, and ultimately destroys the normal structure of the knee joint. The ability of articular cartilage to self‑repair once damaged is limited, due to its inability to obtain nutrients from blood vessels, nerves and lymphatic vessels, as well as limitations in the extracellular matrix. There are several disadvantages inherent to conventional repair methods, while cartilage tissue engineering (CTE), which combines proinflammatory and anti‑-inflammatory cytokines, offers a new therapeutic approach for OA. The aim of the present review was to examine the proinflammatory factors implicated in OA, including IL‑1β, TNF‑α, IL‑6, IL‑15, IL‑17 and IL‑18, as well as the key anti‑inflammatory factors reducing OA‑related articular damage, including IL‑4, insulin‑like growth factor and TGF‑β. The predominance of proinflammatory over anti‑inflammatory cytokine effects ultimately leads to the development of OA. CTE, which employs mesenchymal stem cells and scaffolding technology, may prevent OA by maintaining the homeostasis of pro‑ and anti‑inflammatory factors.
Key Findings
1
Anti-inflammatory factors including IL-4, insulin-like growth factor, and TGF-β can reduce osteoarthritis-related articular cartilage damage.
2
Cartilage tissue engineering using mesenchymal stem cells and scaffolds may help prevent osteoarthritis by restoring pro- and anti-inflammatory cytokine homeostasis.
3
Limited vascular, neural, and lymphatic access, together with extracellular-matrix constraints, restricts the self-repair capacity of articular cartilage.
4
Osteoarthritis progression is associated with an imbalance favoring proinflammatory over anti-inflammatory cytokine activity in articular cartilage.
5
Proinflammatory cytokines implicated in osteoarthritis include IL-1β, TNF-α, IL-6, IL-15, IL-17, and IL-18.
Research Object
knee articular cartilage in osteoarthritis and cartilage tissue engineering approaches using mesenchymal stem cells and scaffolds
Research Subject
the role and balance of proinflammatory and anti-inflammatory cytokines in articular cartilage damage, osteoarthritis progression, and tissue-engineered cartilage repair
Publication Details
Publication Date
2022-01-24
Journal
Publisher
ISSN
Cited by
209
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by4
The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis2024
Pathogenesis and therapeutic strategies of osteoarthritis: roles of immune cells, inflammatory mediators, and pathogenic signaling pathways2026
Chondrocyte inflammatory-immune responses in osteoarthritis: From pathogenesis to therapeutic intervention2026
Systemic biomarkers of treatment response to methotrexate in people with painful knee osteoarthritis: A biological substudy of the PROMOTE randomised controlled clinical trial2026